FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

448971002: Roflumilast (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2011. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2898209012 Roflumilast (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
2902353013 Roflumilast en Synonym Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Roflumilast Is a Benzamide false Inferred relationship Existential restriction modifier
Roflumilast Is a Substance with phosphodiesterase inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Roflumilast Is a Substance with phosphodiesterase 4 inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Roflumilast Has disposition Phosphodiesterase 4 inhibitor true Inferred relationship Existential restriction modifier
Roflumilast Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Roflumilast Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Roflumilast Is a Substance with benzamide structure true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely roflumilast 500 microgram/1 each conventional release oral tablet Has active ingredient False Roflumilast Inferred relationship Existential restriction modifier
Product containing roflumilast Has active ingredient True Roflumilast Inferred relationship Existential restriction modifier 1
Product containing precisely roflumilast 500 microgram/1 each conventional release oral tablet Has active ingredient False Roflumilast Inferred relationship Existential restriction modifier 1
Product containing precisely roflumilast 500 microgram/1 each conventional release oral tablet Has basis of strength substance True Roflumilast Inferred relationship Existential restriction modifier 1
Product containing precisely roflumilast 500 microgram/1 each conventional release oral tablet Has precise active ingredient True Roflumilast Inferred relationship Existential restriction modifier 1
Product containing roflumilast in oral dose form (medicinal product form) Has active ingredient True Roflumilast Inferred relationship Existential restriction modifier 1
Roflumilast Has active ingredient True Roflumilast Inferred relationship Existential restriction modifier 1
Product containing only roflumilast in oral dose form (medicinal product form) Has active ingredient True Roflumilast Inferred relationship Existential restriction modifier 1
Roflumilast 500microgram tablets (Alliance Healthcare (Distribution) Ltd) Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 500microgram tablets (Alliance Healthcare (Distribution) Ltd) 30 tablet Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 500microgram tablets (Milpharm Ltd) Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 500microgram tablets (Milpharm Ltd) 30 tablet Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 500microgram tablets 90 tablet Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) 90 tablet 9 x 10 tablets Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) 30 tablet 3 x 10 tablets Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 500microgram tablets 30 tablet Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 500microgram tablets Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 500microgram tablets Has active ingredient False Roflumilast Inferred relationship Existential restriction modifier
Daxas 500microgram tablets (Merck Sharp & Dohme Ltd) Has active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Has active ingredient False Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Daxas 250microgram tablets (AstraZeneca UK Ltd) Has active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Daxas 250microgram tablets (AstraZeneca UK Ltd) Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Roflumilast 250microgram tablets 28 tablet Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier
Daxas 250microgram tablets (AstraZeneca UK Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Roflumilast Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start